The Mandatum Life and Ilmarinen-backed nanoparticle technology developer has priced a $76.7m offering that will take place in Sweden and Finland.

Biogen and GlaxoSmithKline-backed CalciMedica has received series C capital to advance a possible Covid-19 treatment through clinical testing.

Clara, an insurance data software provider that counts NewYork-Presbyterian among its investors has added series B funding that will support recruitment.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Zentera Therapeutics has been spun off by oncology therapy developer Zentalis Pharmaceuticals with a series A round led by Tybourne Capital Management.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Led by UCLA’s Sri Kosuri, Octant is working on drugs for complex diseases and will use the series A funding to further develop its platform.

Takeda and existing investor Allianz X took part in a series C round closed in the wake of heightened demand for Amwell's telehealth technology platform.

Asahi Kasei Medical contributed to a round that took the total raised by the microbial detection technology provider past $255m.

Pfizer, Lundbeckfonden Ventures and Biomed Ventures have all taken part in a round for the anti-infective therapy developer that has now passed $90m.